OUP user menu

PAX-5 Expression in Pulmonary Neuroendocrine Neoplasms
Its Usefulness in Surgical and Fine-Needle Aspiration Biopsy Specimens

Gabriel Sica MD, PhD, Madeline F. Vazquez MD, Nassar Altorki MD, Jeffrey Port MD, Paul C. Lee MD, Yifang Liu MD, Elizabeth Hyjek MD, Anjali Saqi MD
DOI: http://dx.doi.org/10.1309/8J2PQHF603WHVL8K 556-562 First published online: 1 April 2008

Abstract

The World Health Organization classification of lung tumors recognizes 4 histologic subtypes of pulmonary neuroendocrine carcinomas (NECs), which include typical carcinoids (TCs), atypical carcinoids (ACs), small cell carcinomas (SCCs), and large cell NECs (LCNECs). These tumors can be misclassified owing to morphologic parallels, indicating the necessity for adjunctive tests for correct classification. We evaluated immunohistochemical expression of PAX-5 in histologic and fine-needle aspiration (FNA) specimens of pulmonary NECs. Staining was stratified by intensity (0 to 3+) and percentage of cells stained as focal (<10%) or diffuse (≥10%). PAX-5 expression was present in 29/37 (78%) of high-grade NECs (22/26 SCCs, 1/2 LCNECs, and 6/9 combined tumors) and none of 51 TCs and ACs; FNA specimens showed concordant staining. This study confirmed that PAX-5 is a useful marker in FNA and surgical specimens for the discrimination of low- to intermediate-grade NECs from high-grade NECs with 100% specificity and 79% sensitivity in surgical specimens.

Key Words:
  • PAX-5
  • Carcinoid
  • Small cell carcinoma
  • Large cell neuroendocrine carcinoma
  • Lung carcinoma